Gemcitabine induces programmed cell death and activates protein kinase C in BG-1 human ovarian cancer cells

Cancer Chemotherapy and Pharmacology

Volumn 41, Issue 5, 1998, Pages 403-412

  Cartee, Leanne ^a   Kucera, Gregory Louis ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Gemcitabine; Ovarian cancer; Programmed cell death; Protein kinase C

Indexed keywords

BISINDOLYLMALEIMIDE; CALPHOSTIN C; DNA FRAGMENT; GEMCITABINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

APOPTOSIS; ARTICLE; CANCER CELL; CELL STRUCTURE; CHROMATIN CONDENSATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; DEOXYCYTIDINE; ENZYME ACTIVATION; FEMALE; HUMANS; MICROSCOPY, ELECTRON, SCANNING; OVARIAN NEOPLASMS; PROTEIN KINASE C; TUMOR CELLS, CULTURED;

EID: 0031905245     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050758     Document Type: Article

References (41)

1. Bhalla K, Holladay C, Arlin Z, Grant S, Ibrado AM, Jasiok M (1991) Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts. Blood 78: 2674
2. Bhalla K, Tang C, Ibrado AM, Grant S, Tourkina E, Holladay C, Hughes M, Mahoney ME, Huang Y (1992) Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells. Blood 80: 2883
3. Bhalla K, Tourkina E, Huang Y, Tang C, Mahoney ME, Ibrado AM (1993) Effect of hemopoietic growth factors G-CSF and pIXY 321 on the activity of high dose Ara-C in human myeloid leukemia cells. Leuk Lymphoma 10 [Suppl]: 123
4. Bouffard DY, Momparler RL (1994) Comparison of cytosine arabinoside and 2′,2′-difluorodeoxycytidine (Gemcitabine) on the induction of apoptotic cell death in HL-60 myeloid leukemic cells. Proc Am Assoc Cancer Res 35: 317
5. Boven E, Schipper H, Erkelens CA, Hatty SA, Pinedo HM (1993) The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer. Br J Cancer 68: 52
6. Carballo E, Colomer D, Vives Corrons JL, Blackshear PJ, Gil J (1995) 2-Phosphorylation of the MARCKS family of protein kinase C substrates in human B chronic lymphocytic leukemia cells. Leukemia 9: 834
7. Chepenik KP, Grunwald GB (1988) Effects of epidermal growth factor and phorbol 12-myristate 13-acetate on protein phosphorylation in mouse embryo palate mesenchyme cells, in vitro. J Craniofacial Genet Dev Biol 8: 147
8. Columbano A (1995) Cell death: current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J Cell Biochem 58: 181
9. Curtis BM, Williams DE, Broxmeyer HE, Dunn J, Farrah T, Jeffrey E, Clevenger W, DeRoos P, Martin U, Friend D, Craig V, Gayle R, Price V, Cosman D, March CJ, Park LS (1991) Enhanced hematopoietic activity of a human granulocyte macrophage colony-stimulating factor-interleukin 3 fusion protein. Proc Natl Acad Sci USA 88: 5809
10. Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S, Robertson M, Ghayur T, Wong WW, Kamen R, Weichselbaum R, et al. (1995) Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J 14: 6148
11. Emoto Y, Kisaki H, Manome Y, Kharbanda S, Kufe D (1996) Activation of protein kinase C delta in human myeloid leukemia cells treated with 1-β-D-abinofuranosyl-cytosine. Blood 87: 1990
12. Geisinger KR, Kute TE, Pettenati MJ, Welander CE, Dennard Y, Collins LA, Berens ME (1989) Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors. Cancer 63: 280
13. Ghayur T, Hugunin M, Talanian RV, Ratnofsky S, Quinlan C, Emoto Y, Pandey P, Datta R, Huang YY, Kharbanda S, Allen H, Kamen R, Wong W, Kufe D (1996) Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med 184: 2399
14. Grant S, Turner A, Jarvis D (1994) Regulation of 1-β-D-arabinofuranosylcytosine-induced apoptosis in myeloid leukemia cells by pharmacologic and physiologic activators of PKC: evidence that potentiation of this process is related to enzyme down-regulation. Proc Am Assoc Cancer Res 35: 312
15. Guchelaar H, Richel DJ, Knapen A van (1996) Clinical, toxicological, and pharmacological aspects of gemcitabine. Cancer Treat Rev 22: 15
16. Gunji H, Kharbanda S, Kufe D (1991) Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β-D-arabinofuranosylcytosine. Cancer Res 51: 741
17. Heinemann V, Hertel LW, Grindey GB, Plunkett W (1988) Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-β-D-arabinofuranosylcytosine. Cancer Res 48: 4024
18. Heinemann V, Xu YZ, Chubb S, Sen A, Hertel LW, Grindey GB, Plunkett W (1990) Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2′,2′-difluorodeoxycytidine. Mol Pharmacol 38: 567
19. Herget T, Brooks SF, Broad S, Rozengurt E (1992) Relationship between the major protein kinase C substrates acidic 80-kDa protein-kinase-C substrate (80 K) and myristoylated alanine-rich C-kinase substrate (MARCKS). Members of a gene family or equivalent genes in different species. Eur J Biochem 209: 7
20. Herget T, Oehrlein SA, Pappin DJ, Rozengurt E, Parker PJ (1995) The myristoylated alanine-rich C-kinase substrate (MARCKS) is sequentially phosphorylated by conventional, novel and atypical isotypes of protein kinase C. Eur J Biochem 233: 448
21. Hiddemann W, Kiehl M, Zuhlsdorf M, Busemann C, Schleyer E, Wormann B, Buchner T (1992) Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia. Semin Oncol 19: 31
22. Huang P, Plunkett W (1995) Fludarabine and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event. Cancer Chemother Pharmacol 36: 181
23. Huang P, Plunkett W (1995) Induction of apoptosis by gemcitabine. Semin Oncol 22: 19
24. Jarvis WD, Povirk LF, Turner AJ, Traylor RS, Gewirtz DA, Pettit GR, Grant S (1994) Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[β-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells. Biochem Pharmacol 47: 839
25. Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239
26. Kerr JF, Gobe GC, Winterford CM, Harmon BV (1995) Anatomical methods in cell death. Methods Cell Biol 46: 1
27. Kharbanda S, Datta R, Kufe D (1991) Regulation of c-jun gene expression in HL-60 leukemia cells by 1-β-D-arabinofuranosylcytosine. Potential involvement of a protein kinase C dependent mechanism. Biochemistry 30: 7947
28. Kucera GL, Capizzi RL (1992) 1-β-D-Arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of choline-phosphotransferase and not via cytidylyltransferase. Cancer Res 52: 3886
29. Lund B, Kristjansen PEG, Hansen HH (1993) Clinical and preclinical activity of 2′,2′-difluorodeoxycytidine (gemcitabine). Cancer Treat Rev 19: 45
30. Obeid LM, Hannun YA (1995) Ceramide: a stress signal and mediator of growth suppression and apoptosis. J Cell Biochem 58: 191
31. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M (1993) Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12: 3679
32. Ormerod MG, O'Neill CF, Robertson D, Harrap KR (1994) Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp Cell Res 211: 231
33. Ray S, Ponnathpur V, Huang Y, Tang C, Mahoney ME, Ibrado AM, Bullock G, Bhalla K (1994) 1-beta-D-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation. Cancer Chemother Pharmacol 34: 365
34. Schwartz LM, Smith SW, Jones ME, Osborne BA (1993) Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci USA 90: 980
35. Schy WE, Hertel LW, Kroin KS, Bloom LB, Goodman MF, Richardson FC (1993) Effect of a template-located 2′,2′,-difluorodeoxycytidine on the kinetics and fidelity of base insertion by klenow (3′-5′ exonuclease) fragment. Cancer Res 53: 4582
36. Stewart BW (1994) Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. J Nat Cancer Inst 86: 1286
37. Vente J de, Kiley S, Garris T, Bryant W, Hooker J, Posekany K, Parker P, Cook P, Fletcher D, Ways DK (1995) Phorbol ester treatment of U937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation. Cell Growth Differ 6: 371
38. Vente JE de, Kukoly CA, Bryant WO, Posekany KJ, Chen J, Fletcher DJ, Parker PJ, Pettit GJ, Lozano G, Cook PP, et al. (1995) Phorbol esters induce death in MCF-7 breast cancer cells with altered expression of protein kinase C isoforms. Role for p53-independent induction of gadd-45 in initiating death. J Clin Invest 96: 1874
39. Wang LM, Kucera GL (1994) Deoxycytidine kinase is phosphorylated in vitro by protein kinase C alpha. Biochim Biophys Acta 1224: 161
40. Yasuda I, Kishimoto I, Tanaka S, Tominga M, Sakura A, Nishizuka Y (1990) A synthetic peptide substrate for selective assay of protein kinase C. Biochem Biophys Res Commun 166: 1220
41. Zhivotovsky B, Burgess DH, Vanags DM, Orrenius S (1997) Involvement of cellular proteolytic machinery in apoptosis. Biochem Biophys Res Commun 230: 481